Position in GSK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$304,562,317
-$93,472,167 QoQ
Shares Held
5,518,433
-32.0% QoQ
Ownership
0.276%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Derivatives in GSK
reported options exposure · as of Sep 30, 2023CallValue
$57,383,750
CallShares
1,583,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Holocene Advisors, LP holds $1,328,883,667 across 8 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
2,429,349 | $460,653,157 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
3,216,892 | $406,422,135 | |
| 3 | LLY |
ELI LILLY & Co
|
176,517 | $211,719,802 | |
| 4 | NVS |
Novartis AG
|
1,037,332 | $162,570,671 | |
| 5 | MRK |
Merck & Co., Inc.
|
628,000 | $80,698,000 | |
| 6 | JNJ |
Johnson & Johnson
|
18,956 | $4,814,255 | |
| 7 | BIIB |
Biogen Inc.
|
4,793 | $1,035,575 | |
| 8 | ABBV |
AbbVie Inc.
|
3,855 | $970,072 |
All Filings in GSK
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $304,562,317 | 5,518,433 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $398,034,484 | 8,116,527 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $306,454,127 | 7,100,420 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $215,405,990 | 5,609,531 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $205,517,327 | 5,305,042 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $17,319,898 | 512,120 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,669,504 | 65,301 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $219,053,257 | 5,689,695 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $373,811,138 | 8,719,644 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $304,801,748 | 8,224,548 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $181,759,638 | 5,014,059 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $57,383,750 | 1,583,000 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $103,991,675 | 2,917,836 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $42,077,584 | 1,182,619 | Shares | Sole | 2023-05-15 | |
| 2022-06-30 | $10,673,556 | 250,000 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||